Current status and future direction of cancer research using artificial intelligence for clinical application
Ryuji Hamamoto,Masaaki Komatsu,Masayoshi Yamada,Kazuma Kobayashi,Masamichi Takahashi,Mototaka Miyake,Shunichi Jinnai,Takafumi Koyama,Nobuji Kouno,Hidenori Machino,Satoshi Takahashi,Ken Asada,Naonori Ueda,Syuzo Kaneko
DOI: https://doi.org/10.1111/cas.16395
IF: 5.7
2024-11-27
Cancer Science
Abstract:This review article investigates the current state of artificial intelligence (AI) in the field of cancer research. After first providing a historical perspective on AI and its introduction into medicine, this article described recent and current advances in AI‐based approaches and devices for medical imaging and omics analysis, particularly in the field of oncology, highlighting both approved systems and systems under development. Finally, this article critically reviewed the current state of AI research in medicine and described the main limitations and potential approaches to overcome them. The expectations for artificial intelligence (AI) technology have increased considerably in recent years, mainly due to the emergence of deep learning. At present, AI technology is being used for various purposes and has brought about change in society. In particular, the rapid development of generative AI technology, exemplified by ChatGPT, has amplified the societal impact of AI. The medical field is no exception, with a wide range of AI technologies being introduced for basic and applied research. Further, AI‐equipped software as a medical device (AI‐SaMD) is also being approved by regulatory bodies. Combined with the advent of big data, data‐driven research utilizing AI is actively pursued. Nevertheless, while AI technology has great potential, it also presents many challenges that require careful consideration. In this review, we introduce the current status of AI‐based cancer research, especially from the perspective of clinical application, and discuss the associated challenges and future directions, with the aim of helping to promote cancer research that utilizes effective AI technology.
oncology